USFDA completes inspection of Jubilant Pharmova's API Manufacturing Facility at Nanjangud, India

Jubilant Pharmova Limited today announced that the United States Food and Drug Administration (USFDA) has concluded inspection of the Active Pharmaceutical Ingredients (API) manufacturing facility at Nanjangud on December 13, 2022.

The US FDA has issued eight observations pursuant to the completion of the inspection. The company will submit an action plan on the observations and will engage with US FDA for next steps.

Shares of Jubilant Pharmova Limited was last trading in BSE at Rs. 399.65 as compared to the previous close of Rs. 402.75. The total number of shares traded during the day was 7964 in over 590 trades.

The stock hit an intraday high of Rs. 407.05 and intraday low of 397.00. The net turnover during the day was Rs. 3198130.00.

Source : Equity Bulls

Keywords

JubilantPharmova INE700A01033 USFDA Inspection API ManufacturingFacility Nanjangud 8Observations